Skip to main content
editorial
. 2023 Jan 11;25(4):628–630. doi: 10.1093/neuonc/noad005

Figure 1.

Figure 1.

Development status for medulloblastoma cellular immunotherapy, as discussed in Schakelaar et al. ALT, adoptive lymphocyte transfer; DC, dendritic cell; Haplo, haploidentical; HCT, hematopoietic cell transplant; ttRNA, total tumor RNA. Images created with Biorender.com.